These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 11712792)
1. Biological indicators of aggressiveness in T1 ductal invasive breast cancer. Bucci B; Carico E; Rinaldi A; Froio F; Puce YM; D'Agnano I; Vecchione A; Brunetti E Anticancer Res; 2001; 21(4B):2949-55. PubMed ID: 11712792 [TBL] [Abstract][Full Text] [Related]
2. Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Kokawa K; Shikone T; Otani T; Nakano R Cancer; 1999 Apr; 85(8):1799-809. PubMed ID: 10223575 [TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Ikeguchi M; Hirooka Y; Kaibara N Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288 [TBL] [Abstract][Full Text] [Related]
4. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients. Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147 [TBL] [Abstract][Full Text] [Related]
5. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis. Schiller AB; Clark WS; Cotsonis G; Lawson D; DeRose PB; Cohen C Cytometry; 2002 Aug; 50(4):203-9. PubMed ID: 12210599 [TBL] [Abstract][Full Text] [Related]
6. Correlation between BRCA1 expression and apoptosis-related biological parameters in sporadic breast carcinomas. Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K Anticancer Res; 2002; 22(6B):3615-9. PubMed ID: 12552965 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients. Kapranos N; Karaiosifidi H; Valavanis C; Kouri E; Vasilaros S Anticancer Res; 1997; 17(4A):2499-505. PubMed ID: 9252670 [TBL] [Abstract][Full Text] [Related]
8. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression. Jäckel MC; Dorudian MA; Marx D; Brinck U; Schauer A; Steiner W Cancer; 1999 Feb; 85(3):591-9. PubMed ID: 10091732 [TBL] [Abstract][Full Text] [Related]
9. Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas. Zhang GJ; Kimijima I; Abe R; Kanno M; Katagata N; Hara K; Watanabe T; Tsuchiya A Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2329-35. PubMed ID: 9815631 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. Bargou RC; Wagener C; Bommert K; Mapara MY; Daniel PT; Arnold W; Dietel M; Guski H; Feller A; Royer HD; Dörken B J Clin Invest; 1996 Jun; 97(11):2651-9. PubMed ID: 8647960 [TBL] [Abstract][Full Text] [Related]
11. Bax expression in untreated breast cancer: an immunocytometric study of 255 cases. Martínez-Arribas F; Martín-Garabato E; Zapardiel I; Sánchez J; Lucas AR; Tejerina A; Schneider J Anticancer Res; 2008; 28(5A):2595-8. PubMed ID: 19035283 [TBL] [Abstract][Full Text] [Related]
12. Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma. Lee WY; Jin YT; Tzeng CC Anticancer Res; 1996; 16(5A):3007-12. PubMed ID: 8917421 [TBL] [Abstract][Full Text] [Related]
13. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up. el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer. Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis in prostate cancer: bax correlation with stage. Amirghofran Z; Monabati A; Gholijani N Int J Urol; 2005 Apr; 12(4):340-5. PubMed ID: 15948719 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas. Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312 [TBL] [Abstract][Full Text] [Related]
17. [Expression of the genes FHIT, Bcl-2 and Bax in breast infiltrating ductal carcinoma and clinicopathological significance thereof]. Wang ZB; Zhao P; Liu M; Li XH Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(31):2171-6. PubMed ID: 17064501 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer. Sierra A; Castellsagué X; Tórtola S; Escobedo A; Lloveras B; Peinado MA; Moreno A; Fabra A Clin Cancer Res; 1996 Nov; 2(11):1887-94. PubMed ID: 9816145 [TBL] [Abstract][Full Text] [Related]
19. The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer. Sjöström J; Blomqvist C; von Boguslawski K; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Wist E; Valvere V; Takayama S; Reed JC; Saksela E Clin Cancer Res; 2002 Mar; 8(3):811-6. PubMed ID: 11895913 [TBL] [Abstract][Full Text] [Related]
20. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers. Sharma H; Sen S; Mathur M; Bahadur S; Singh N Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]